ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA clears Celltrion, Teva's biosimilar version of Roche's Herceptin
firstwordpharma
December 17, 2018Celltrion and Teva announced that the FDA has approved Herzuma (trastuzumab-pkrb), a biosimilar referencing Roche's Herceptin (trastuzumab), for the treatment of certain patients with HER2-overexpressing breast cancer. Specifically, Herzuma was cleared fo -
FDA clears Celltrion, Teva's biosimilar version of Roche's Herceptin
firstwordpharma
December 17, 2018Celltrion and Teva announced that the FDA has approved Herzuma (trastuzumab-pkrb), a biosimilar referencing Roche's Herceptin (trastuzumab), for the treatment of certain patients with HER2-overexpressing breast cancer. Specifically, Herzuma was cleared fo
Pharma Sources Insight January 2025
